Search
for
Sort by
Research 121–150 of 1000+
- The genetics of alopecia areata: New approaches, new findings, new treatments
- Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds
- Macrophage Related Chronic Inflammation in Non-Healing Wounds
- The Thinning Top: Why Old People Have Less Hair
- Pharmaceutical, Pharmacological and Pharmachemistrical Prospectus of ayurvedic Formulations for Alopecia: A Comprehensive Evidence Based Systematic Review
- Effect of physical stimuli on hair follicle deposition of clobetasol-loaded Lipid Nanocarriers
- Photobiomodulation devices for hair regrowth and wound healing: a therapy full of promise but a literature full of confusion
- Intercellular Adhesion Molecule-1 and Hair Follicle Regression
- Androgens in cervical cancer: Their role in epidemiology and biology
- Biomimetic Cell Membrane‐Coated Scaffolds for Enhanced Tissue Regeneration
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Scar Inhibition in Wound Healing: Mechanisms, Design, and Recent Advances
- The Mitochondrial Blueprint of Skin Aging: From Damage Signals to Dermatologic Interventions
- Exploring the Relationship Between Immune Cells and Non-Scarring Hair Loss: A Mendelian Randomization Study
- A Review on Nanoparticle Based Herbal Remedies for the Management of Alopecia
- Triggering of drug release of particles in hair follicles
- Diagnosis and Management of Melanoma of the Scalp: A Review of the Literature
- Enhancing alopecia areata management: Nanocrystal-driven strategy for targeting hair follicles
- Therapeutic and Diagnostic Applications of Nanotechnology in Dermatology and Cosmetics
- Alopecia and Hair Damage Induced by Oncological Therapy
- Hair loss and its management in children
- Methodologic considerations in evaluating early clinical outcomes of GT20029 for androgenetic alopecia
- Emotional burden and current management practices in pediatric alopecia areata: An online survey among physicians
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Targeting receptor–regulator interactions
- Understanding Alopecia Areata: Types, Causes, and Latest Therapeutic Approaches
- Targets to treat androgen excess in polycystic ovary syndrome
- Potential targets in the discovery of new hair growth promoters for androgenic alopecia
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice